scholarly journals Changes and Continuities in the Global Health Governance of Coronaviruses

2020 ◽  
Vol 9 (2) ◽  
pp. 185
Author(s):  
Sukmawani Bela Pertiwi

This paper aims to examine changes and continuities in terms of actors and policies in the global health governance on coronaviruses in order to understand the available tools, the characters and the extent they meet the required responses of a pandemic. In doing so, this paper examines actors and policies in the governance of three occurrences of coronaviruses, i.e. SARS, MERS, and the COVID-19. Actors and policies are mapped based on its function in a pandemic: (a) surveillance and knowledge dissemination, (b) material and financial assistance both for emergency and long term purposes, and (c) rule-making behavior. This paper found that the larger scale of the COVID-19 pandemic has led more actors involved in the global governance of COVID-19 than during MERS and SARS. WHO still dominates the surveillance and knowledge dissemination as well as rule making leadership. It also leads in providing material assistance to affected countries. Yet, with the significant impacts to global economy, global financial institutions dominate the provision of financial assistance both for short term and long term commitment. This imbalanced crowd in this last aspect, therefore, causes a changing dominant approach of the GHG on coronaviruses from the previously dominating evidence-based scientific approach to economic approach.

2016 ◽  
Vol 1 (1) ◽  
Author(s):  
Dr. Kamlesh Kumar Shukla

FIIs are companies registered outside India. In the past four years there has been more than $41 trillion worth of FII funds invested in India. This has been one of the major reasons on the bull market witnessing unprecedented growth with the BSE Sensex rising 221% in absolute terms in this span. The present downfall of the market too is influenced as these FIIs are taking out some of their invested money. Though there is a lot of value in this market and fundamentally there is a lot of upside in it. For long-term value investors, there’s little because for worry but short term traders are adversely getting affected by the role of FIIs are playing at the present. Investors should not panic and should remain invested in sectors where underlying earnings growth has little to do with financial markets or global economy.


Author(s):  
Mary Robinson

Institutions matter for the advancement of human rights in global health. Given the dramatic development of human rights under international law and the parallel proliferation of global institutions for public health, there arises an imperative to understand the implementation of human rights through global health governance. This volume examines the evolving relationship between human rights, global governance, and public health, studying an expansive set of health challenges through a multi-sectoral array of global organizations. To analyze the structural determinants of rights-based governance, the organizations in this volume include those international bureaucracies that implement human rights in ways that influence public health in a globalizing world. Bringing together leading health and human rights scholars and practitioners from academia, non-governmental organizations, and the United Nations system, this volume explores: (1) the foundations of human rights as a normative framework for global health governance, (2) the mandate of the World Health Organization to pursue a human rights-based approach to health, (3) the role of inter-governmental organizations across a range of health-related human rights, (4) the influence of rights-based economic governance on public health, and (5) the focus on global health among institutions of human rights governance. Contributing chapters map the distinct human rights activities within a specific institution of global governance for health. Through the comparative institutional analysis in this volume, the contributing authors examine institutional efforts to operationalize human rights in organizational policies, programs, and practices and assess institutional factors that facilitate or inhibit human rights mainstreaming for global health advancement.


Author(s):  
Jeremy Youde

While Chapter 3 focuses primarily on the evolution of global health governance, Chapter 4 pays more attention to its contemporary manifestation as a secondary institution within international society. This chapter discusses the current state of the global health governance architecture—who the important actors are, how they operate, how they have changed over the past twenty-five years, and how they illustrate the fundamental beliefs and attitudes within the global health governance system. In particular, the chapter discusses the relative balance between state-based and non-state actors, as well as public versus private actors. This chapter highlights five key players within contemporary global health governance: states; the World Health Organization; multilateral funding agencies; public–private partnerships; and non-state and private actors


Author(s):  
Jeremy Youde

China possesses the world’s largest economy, but that economic clout has not necessarily translated into taking leading roles within existing global health governance institutions and processes. It is a country that both contributes to and receives financial assistance from global health institutions. It has incorporated health into some of its foreign policy activities, but it has largely avoided proactively engaging with the values and norms embodied within the global health governance system. This ambivalent relationship reflects larger questions about how and whether China fits within international society and what its engagement or lack thereof might portend for international society’s future. This chapter examines China’s place within global health governance by examining its interactions with international society on global health issues, its use of health as a foreign policy tool, and its relationships with global health governance organizations.


Author(s):  
Jennifer Prah Ruger

The global health governance (GHG) literature frames health variously as a matter of security and foreign policy, human rights, or global public good. Divergence among these perspectives has forestalled the development of a consensus vision for global health. Global health policy will differ according to the frame applied. Fundamentally, GHG today operates on a rational actor model, encompassing a continuum from the purely self-interest-maximizing position at one extreme to a more nuanced approach that takes others’ interests into account when making one’s own calculations. Even where humanitarian concerns are clearly and admirably at play, however, the problem of motivations remains. Often narrow self-interest is also at work, and actors obfuscate this behind altruistic motives.


Author(s):  
Yanzhong Huang

Focusing on BRICS countries, this chapter examines the profound implications arising from the growing and future role of emerging powers in global health governance (GHG). At the beginning of the twenty-first century, not only did BRICS countries shift towards net donors, but also their efforts in global health agenda setting and norm development increased. Their policy and practice in conducting health diplomacy constitute an alternative to the existing GHG paradigm. However, their role in GHG remains limited and mixed, as shown in the relatively small size of development assistance for health (DAH), a selective and state-centric approach to developing and participating in global health institutions, and the lack of progress working together and translating policy rhetoric into action. It is still too early to view these efforts as a counterbalance or counterforce to industrialized countries in GHG.


Sign in / Sign up

Export Citation Format

Share Document